0 results for 'Goodwin Procter'
US Firms Line Up Behind $16B Three-Way Drug Manufacturing Deal
Skadden, Goodwin Procter and Jones Day are behind the $16.5 billion acquisition of an American pharmaceutical company by the holding company of Novo Nordisk, maker of weight-loss drug Wegovy and Type 2 diabetes shot Ozempic.Deal Watch: Hogan Lovells and Wachtell Land Big Sports Deals
Professional and college sports were center stage this past week for lawyers.Goodwin, Citing Performance Reviews, Parts With Number of Associates
As part of an attorney evaluation process, "each year, the firm facilitates the transition of lawyers who are not performing at the high standards that our clients expect of us," Goodwin said in a statement Thursday.Kirkland Adds 5-Lawyer Investment Funds Team From Goodwin
The group hires come two years after Kirkland lured a Proskauer funds group.McDermott Lands Julia Boyd for PE Group, Anticipating Strong Year for Transactions
Boyd, a co-founder of the Senior Women in Private Equity network, is moving her practice from Reed Smith to McDermott, anticipating the bulk of her client base to join her.View more book results for the query "Goodwin Procter"
Deal Watch: Big Week in Multiple Verticals in M&A
Skadden and Paul Weiss had multiple big deals in the last few days, as deals from tech, energy and PE power the week. And there were four new IPOs.Latest Norton Rose Fulbright Departure Sees Fintech Practice Head Relocate to Steptoe
"One troubling fact was that it was never explained internally, even to partners, why our global C-suite all the sudden departed in a short period of time," Stephen Aschettino said of his former firm. "The reasons for that have never been articulated."Deal Watch: Kirkland, Akin Drive Energy Deals as Big Law Leans Into Sector for M&A
Four of the five announced M&A deals of more than $1 billion in the past week involved the energy and infrastructure sectors.Kirkland, Cooley, Crowell Bring 'Real Impact' C-Suite Leaders to Start the Year
The latest Big Law moves are part of a broader movement to increase skill sets and drive firms forward strategically and financially, at the C-level and elsewhere.Deal Watch: Cravath, Skadden, Shearman, K&L Gates Steer Health Care Deals Amid Industry Momentum
"We are cautiously optimistic the healthcare and pharma IPO market will gain strength in 2024," said McDermott partner Todd Kornfeld.Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now